Navigation Links
Bracco Showcases Its Commitment to Diagnostic Imaging to Improve Patient Care and Clinical Outcomes at the 2016 Radiological Society of North America Annual Meeting (RSNA)
Date:11/29/2016

MONROE TOWNSHIP, N.J., Nov. 29, 2016 /PRNewswire/ -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, today announced a review of key milestones the company has achieved this year in diagnostic imaging and contrast media that reinforces its commitment to providing innovative products to the healthcare community.

"As a leader in the imaging marketplace, we are committed to the discovery and development of imaging agents and solutions aimed at providing quality products and services that enhance diagnostic efficacy, patient safety and cost effectiveness," said Fulvio Renoldi Bracco, Head of Global Business Unit Imaging at Bracco Imaging. "Our work continues to demonstrate Bracco's commitment to innovation and to providing solutions that address the evolving needs of patients."

The following summary provides a snapshot of major milestones impacting Bracco this year:


  • U.S. Food and Drug Administration (FDA) approval and recent launch of the first and only syringe-less power injector in the U.S., designed to streamline workflow and improve patient care for computed tomography (CT)
  • The company received the first U.S. FDA approval for contrast enhanced ultrasonography of the liver in adult and pediatric patients; first ultrasound contrast agent approved for use in pediatrics in the world. This year, the Centers for Medicare & Medicaid Services approved coverage and coding for abdominal ultrasound with contrast under the Hospital Outpatient Prospective Payment System.
  • The company received the first and only U.S. FDA approvals of two of its barium-based products (one for CT; one for contrast radiography)
  • The company received an Innovative Technology Designation from Vizient for its injectable suspension for contrast echocardiography 
  • Virtual colonoscopy received highest grade by The U.S. Preventive Services Task Force as an alternative screening tool in detecting colorectal cancer after finding that computed tomography colonography was proven to reduce the incidence and mortality of colorectal cancer, the second deadliest cancer in the U.S. Bracco markets the latest innovative CO2 insufflator and a stool marker, or "fecal tagging" agent, for CT colonoscopy.

"We are very proud of our accomplishments so far this year, which are all aimed at improving the diagnostic performance of medical imaging procedures and helping healthcare professionals deliver quality care to their patients," said Alberto Spinazzi, MD, Senior Vice President, Head of Global Medical and Regulatory Affairs, Bracco Group. "Effective, safe, and high quality diagnostic imaging is key for medical decision-making, and we will continue to research and develop innovative ways to meet the demands of the evolving diagnostic imaging sector."

About Bracco Imaging

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world's leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs.

Bracco Imaging offers a product and solution portfolio for all key diagnostic imaging modalities: X-ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers. The diagnostic imaging portfolio is completed by a range of medical devices and advanced administration systems for contrast imaging products.

The Company operates in over 100 markets worldwide, either directly or indirectly, through subsidiaries, joint ventures, licenses and distribution partnership agreements. With on-going research covering all key modalities, Bracco Imaging has a strong presence in key geographies: North America, Europe and Japan operating through the Joint Venture Bracco-Eisai Co. Ltd. The Company also operates in Brazil, South Korea, and China through the Joint Venture Bracco Sine Pharmaceutical Corp. Ltd.

Operational investments have been made in order to achieve top quality, compliant and sustainable eco-friendly production. Manufacturing activities are located in Italy, Switzerland, Japan, China, and Germany.

Bracco Imaging is an innovative Research and Development (R&D) structure with an efficient process oriented approach and a track record of innovation in the diagnostic imaging industry. R&D activities are managed in the three Research Centers located in Italy, Switzerland, and the USA.

To learn more about Bracco Imaging, visit  www.braccoimaging.com.

Press Contact:

Kimberly Gerweck Bracco
Diagnostics Inc.
Kimberly.Gerweck@diag.bracco.com
609.514.2249

Logo - http://photos.prnewswire.com/prnh/20160201/327852LOGO   

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bracco-showcases-its-commitment-to-diagnostic-imaging-to-improve-patient-care-and-clinical-outcomes-at-the-2016-radiological-society-of-north-america-annual-meeting-rsna-300366825.html


'/>"/>
SOURCE Bracco Diagnostics Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Bracco Diagnostics Inc. Receives Second U.S. FDA Approval for Barium-Based Products, The First in Computed Tomography
2. Bracco Diagnostics Inc. Receives First U.S. FDA Approval For Barium-Based Product Used For Contrast Radiography
3. Ikonopedia Showcases Closed-Loop Tracking System Designed to Keep Breast Imaging Patients Safe at RSNA
4. FUJIFILM Showcases Latest Dynamic Visualization II * Image Processing At RSNA 2016
5. FUJIFILM SonoSite Showcases Comprehensive Portfolio Of Point-Of-Care Ultrasound At RSNA 2016
6. IBM Watson Health Showcases Progress Tackling Diabetes at American Diabetes Associations 76th Scientific Sessions
7. Datamonitor Healthcare Showcases Benefits of $100m Informa (INF.L) Investment Program
8. iCAD Showcases Latest Technology Supporting Use of Xoft System for Non-melanoma Skin Cancer Treatment at AAD 2016
9. AccuTEC Blades Showcases Dermatological Blades at Annual Meeting of the American Academy of Dermatology
10. Chicago Dental Convention Showcases New Innovations and Technologies in Dentistry
11. Independent Baylor University Study Showcases Economic Impact of Allergan on Waco and Central Texas Economies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... Pa. (PRWEB) , ... June 19, 2019 , ... ... nuclear receptor and in vitro toxicology testing solutions, announced the addition of the ... kit expands INDIGO’s existing in vitro toxicology offerings and allows researchers to perform ...
(Date:6/18/2019)... ... June 18, 2019 , ... MY ... W Olympic Blvd Suite 350 Los Angeles, CA, 90064, bringing holistic solutions to ... , MY Education Guru has created individual programs to assist students who have ...
(Date:6/18/2019)... ... June 18, 2019 , ... Officials with American Physician ... are pleased to announce the acquisition of Leading Edge Medical Associates (LEMA), a ... physicians and 9 advanced practice clinicians care for 115,000 emergency department patients annually ...
Breaking Medicine Technology:
(Date:6/14/2019)... ... ... reviewed and approved providers for May 2019. , FL TOP DOCS INCLUDE: , BARIATRIC MEDICINE/SURGERY, ... Dr. Debbie Berlin , CARDIOLOGY, Dr. Nirat Beohar ... Dr. Yamilet Tirado , DERMATOLOGY, Dr. B. Jennifer Berkes ...
(Date:6/13/2019)... PETERSBURG, Fla. (PRWEB) , ... June 13, 2019 ... ... and research company today announced that it has signed a memorandum of understanding ... (API) for its drug product MMJ-001 and MMJ-002. , MMJ BioPharma Cultivation will ...
(Date:6/13/2019)... ... 13, 2019 , ... In Partnership with the Smiles for Everyone Foundation ... at its Mesquite, TX office on July 13th. , Dental services provided include same-day ... extractions . For more information, please visit the Monarch Dental website . , ...
(Date:6/13/2019)... ... June 13, 2019 , ... The ... present the second annual Women|Future Conference and the advisory board that ... better position themselves and their organizations in tomorrow's marketplace. , The mission of ...
(Date:6/13/2019)... ... ... Clinical Ink , a global clinical trial technology company that is ... chief business officer at Clinical Ink, has been invited to be a panelist in ... July 1, 2019, in Washington, D.C. The workshop, convened under a cooperative agreement with ...
Breaking Medicine News(10 mins):